New York Times (06/27/97) P. B9
Due to lack of demand, Johnson & Johnson's Direct Access
Diagnostics unit is taking its Confide home HIV test off the
market. The company, which noted that it expected greater
demand, said that after a year on the market, about 90,002
tests had been sold. The only other competitor in the home
HIV blood testing market is Home Access Health Corp., which
reports sales of around 150,000 units thus far in 1997.
Direct Access stopped shipping Confide on Thursday and will
ask retailers to pull them from the shelves and return
inventories. The company will continue to process results
until Aug. 8, after which time anyone sending in tests will be
informed about how to obtain a refund. Direct Access' result
center, which provides counseling and referrals, will remain
open until August 29. After that date, callers will be
referred to the CDC National AIDS Hotline.